Keli Walbert
Vermögen: - $ am 30.06.2026
Vermögen: - $ am 30.06.2026
Keli Walbert is currently an Independent Director at Spruce Biosciences, Inc. since 2025.
Former positions include Independent Director at Apellis Pharmaceuticals, Inc. from 2025 to 2026, and Executive Vice President-US Commercial at Horizon Therapeutics Ltd. (Ireland) from 2019 to 2023.
Education includes graduate studies at Northwestern University and undergraduate studies at the University of Louisville.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.05.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 11.12.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 14.05.2026 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | 01.01.2023 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Louisville
University of Louisville Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spruce Biosciences, Inc.
Spruce Biosciences, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company which develops novel therapies for endocrine diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen